Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-27

FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd.)

View source ↗

Summary

The FDA approved Advagen Pharma Ltd.'s supplemental application for dorzolamide hydrochloride, authorizing a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide hydrochloride (dorzolamide hydrochloride)

Snippet

SUPPL AP for DORZOLAMIDE HYDROCHLORIDE (DORZOLAMIDE HYDROCHLORIDE)